January 20th 2023
Prompt intervention may reduce treatment burden and improve the prognosis of fungal endophthalmitis after cataract surgery.
November 14th 2022
Phase 3 study of CPN-302: Positive topline results for post-cataract surgery drug candidate
August 13th 2022The companies note that data from Study CPN-302 confirm the results in the first Phase 3 study, CPN-301, and they demonstrate the clear benefits of treating patients after cataract surgery with APP13007.
Enrolment begins in Phase 2 study for therapeutic for persistent corneal epithelial defects
July 10th 2022Kiora Pharmaceuticals announced it has enrolled the first patient as a part of a Phase 2 study evaluating KIO-201 topical eye drops in patients with PCED, a rare ocular surface condition characterized by non-healing wounds on the eye surface.
Positive topline data from Saturn-2 Phase 3 trial encourages Tarsus to file NDA in 2022
May 8th 2022TP-03 met the primary and all secondary endpoints, effectively resolved Demodex blepharitis and was well-tolerated with no serious treatment-related adverse events. 56% of patients on TP-03 achieved the primary endpoint of complete collarette cure.
Predicting metastasis with novel prognostic liquid biopsy for uveal melanoma
May 4th 2022Investigators from the Karolinska Institutet and St. Erik Eye Hospital, Stockholm, Sweden, reported that they have developed a prognostic test, referred to as serUM, that they believe is a strong predictor of metastasis of uveal melanoma.
High performance microscopy for non-invasive conjunctival goblet cell examination examined by study
April 13th 2022A team of investigators from Pohang University of Science and Technology has found that conjunctival goblet cell examination is important for the precise diagnosis and effective treatment of ocular surface diseases; however, CGC examination has not been possible until now due to lack of non-invasive devices.
Differences in pupil sizes distinguish between active and resolved COVID-19 cases
January 24th 2022The investigators believe that, based on their findings, the impact of COVID-19 on the autonomous nervous system warrants further prospective studies and assessment of pupillary function might be a useful test for determining autonomic dysfunction.
Macrophage-mediated cytokine storm associated with COVID-19 infection in diabetic patients
November 5th 2021A team of investigators from the University of Michigan may have unlocked a potential new recipe for counteracting the impact that COVID-19 has on patients with underlying disease processes such as type 2 diabetes.